Science 37 Logo.jpg
CORRECTION-- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial
12 juin 2024 15h55 HE | Science 37, Inc.
Science 37, a leader in enhancing patient access to clinical trials, surpasses enrollment targets and helps accelerate Phase 2 rare disease study.
Science 37 Logo.jpg
Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial
12 juin 2024 08h00 HE | Science 37, Inc.
Science 37, a leader in enhancing patient access to clinical trials, surpasses enrollment targets and helps accelerate Phase 2 rare disease study.
22157.jpg
Decentralised Clinical Trials Market Report 2024-2034
11 juin 2024 06h57 HE | Research and Markets
Dublin, June 11, 2024 (GLOBE NEWSWIRE) -- The "Decentralised Clinical Trials Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Decentralised...
DMR Logo.png
CDMO Market Forecast USD 530.3 Billion by 2033 at 7.7% CAGR Growth Rate | Dimension Market Research
10 juin 2024 10h57 HE | Dimension Market Research
New York, June 10, 2024 (GLOBE NEWSWIRE) -- Overview The Global CDMO Market size is expected to reach USD 272.4 billion by 2024 and is further anticipated to reach USD 530.3 billion by 2033 at a...
22157.jpg
Global Ferroptosis Targeting Therapy Clinical Trials Market 2024 - Clinical Trials Insight on 10+ Key Therapies in Trials
29 mai 2024 07h37 HE | Research and Markets
Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "Global Ferroptosis Targeting Therapy Market Opportunity & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering....
LOGO.png
IMAC Holdings Announces Leadership Succession
24 mai 2024 09h00 HE | IMAC Holdings, Inc.
Faith Zaslavsky appointed as CEO to succeed Jeff Ervin FRANKLIN, Tenn., May 24, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC”) today announced leadership transitions to the...
22157.jpg
Single Domain Antibody Platforms MarketResearch 2024-2031: Strategic Collaborations Driving Expansion, Focus on Pioneering Cancer Treatments, US Leads Innovations
24 mai 2024 04h28 HE | Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Single Domain Antibody Platforms Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
Director of the Ivy Brain Tumor Center and director of neurosurgical oncology at Barrow Neurological Institute
Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant improvement in overall survival of newly diagnosed glioblastoma patients
23 mai 2024 17h09 HE | Ivy Brain Tumor Center
Phoenix, AZ, May 23, 2024 (GLOBE NEWSWIRE) -- Results will be presented at American Society of Clinical Oncology (ASCO) Annual MeetingMedian overall survival was 20.3 months, nearly doubling the...
22157.jpg
Global Flow Cytometry Market Report 2024-2029, Featuring Agilent Technologies, BD, Bio-Rad Laboratories, Cytek Biosciences, Danaher, Miltenyi Biotec, Sony Biotechnology and Standard Biotools
15 mai 2024 09h48 HE | Research and Markets
Dublin, May 15, 2024 (GLOBE NEWSWIRE) -- The "Flow Cytometry: Products, Technologies and Global Markets 2024-2029" report has been added to ResearchAndMarkets.com's offering. The global market...
Science 37 Logo.jpg
Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance
13 mai 2024 08h00 HE | Science 37, Inc.
Science 37 Holdings, Inc. today announced the preliminary outcome of its recent FDA Inspection focusing on critical areas and documentation.